CSIMarket Company Name, Ticker, Industry, else..
 
Celyad Oncology Sa  (NASDAQ: CYAD)
 

CYAD's Market share relative to its competitors, as of Q4 2022

As of Q4 2022 (Revenue in Millions of $)

Date modified: 2026-05-28T06:06:10+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q4 2022		 MARKET SHARE
12 Months
Q4 2022		 MARKET SHARE
MRQ
Q4 2022		 MARKET SHARE
A Quarter Before
Q3 2022
Celyad Oncology Sa 0.01 0.00% 0.00 % 0.00 %
Arcellx Inc 22.29 1.00% 0.30% 1.09%
Gracell Biotechnologies Inc 0.00 0.00% 0.00% 0.00%
Legend Biotech Corporation 1,028.90 46.25% 46.25% 0.00%
Nkarta Inc 0.00 0.00% 0.00% 0.00%
Instil Bio Inc 8.97 0.40% 0.41% 0.49%
52 more competitors available

Sign in to see all competitors for Celyad Oncology Sa.

Sign In Create Free Account



CYAD's Market share relative to its competitors, as of Q4 2022 within the Major Pharmaceutical Preparations Industry
As of Q4 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2022		 MARKET SHARE
12 Months Ending
Q3 2022		 MARKET SHARE
MRQ
Q4 2022		 MARKET SHARE

Q3 2022
Celyad Oncology Sa 0.00% 0.00% 0.00 % 0.00 %
Gracell Biotechnologies Inc 0.00% 0.00% 0.00% 0.00%
Legend Biotech Corporation 47.72% 39.63% 47.72% 39.63%
Nkarta Inc 0.00% 0.00% 0.00% 0.00%
Bellicum Pharmaceuticals Inc 0.07% 0.09% 0.19% 0.00%
Geron Corporation 9.48% 11.60% 10.69% 11.78%
41 more companies available

Sign in to see all industry competitors for Celyad Oncology Sa.

Sign In Create Free Account



CYAD's Market share relative to its competitors, as of Q4 2022 within the Healthcare Sector
As of Q4 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2022		 MARKET SHARE
12 Months Ending
Q3 2022		 MARKET SHARE
MRQ
Q4 2022		 MARKET SHARE

Q3 2022
Celyad Oncology Sa 0.00% 0.00% 0.00 % 0.00 %
Arcellx Inc 1.00% 3.40% 0.30% 1.09%
Gracell Biotechnologies Inc 0.00% 0.00% 0.00% 0.00%
Legend Biotech Corporation 46.28% 37.43% 46.28% 37.43%
Nkarta Inc 0.00% 0.00% 0.00% 0.00%
Instil Bio Inc 0.40% 0.54% 0.41% 0.49%
51 more companies available

Sign in to see all sector competitors for Celyad Oncology Sa.

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Celyad Oncology Sa's market divisions, geographic dispersion, segments, products, and services, visit Celyad Oncology Sa's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.